SAXONOV SERGE (Chief Executive Officer) sold 1.7% of their position (18.55K shares) of 10X GENOMICS, INC. on the open market
Open‑market sale worth $1.17M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/26/2026ACC: 0001610717-26-000392
DirectorOfficer10% Owner· Chief Executive Officer
Since Sep 2019
-18.55K
Net shares
Net seller
$1.17M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
18.55K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−18.55K
Price / share
$63.02
Trade value
$1.17M
% of position
1.7%
8/24/2026
1.10M→1.09M
Total
Net shares
−18.55K
Net value
-$1.17M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/24/2026 | S · Sale | −18.55K | $63.02 | $1.17M | 1.7% | 1.10M | 1.09M |
| Total | −18.55K | -$1.17M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Class A Common Stock
IndirectShares owned27.00
Class A Common Stock
IndirectShares owned71.64K
Class A Common Stock
IndirectShares owned213.25K
Total
284.92K indirect284.92K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 27.00 | Indirect |
| Class A Common Stock | 71.64K | Indirect |
| Class A Common Stock | 213.25K | Indirect |
| Total | 284.92K | 284.92K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported